Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    RxSight Inc.

    NASDAQ: RXST · Real-Time Price · USD
    14.06
    -0.15 (-1.06%)
    At close: Jun 16, 2025, 3:59 PM
    13.83
    -1.64%
    After-hours: Jun 16, 2025, 06:29 PM EDT
    -1.06%
    Bid 13
    Market Cap 571.36M
    Revenue (ttm) 158.4M
    Net Income (ttm) -26.55M
    EPS (ttm) -0.66
    PE Ratio (ttm) -21.3
    Forward PE -26.86
    Analyst Buy
    Ask 16.5
    Volume 264,514
    Avg. Volume (20D) 1,032,944
    Open 14.13
    Previous Close 14.21
    Day's Range 13.89 - 14.34
    52-Week Range 12.53 - 60.81
    Beta 1.29

    About RXST

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol RXST
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for RXST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    4 weeks ago
    +15.01%
    RxSight shares are trading higher after Wells Farg... Unlock content with Pro Subscription
    2 months ago
    -37.94%
    RxSight shares are trading lower after the company issued FY25 revenue guidance below estimates.
    news image

    1 week ago · seekingalpha.com

    RxSight: Valuation Blowout Creates Opportunity

    RxSight is a promising growth stock in the medical device sector, focusing on innovative cataract treatments with a large addressable market. Despite a recent decline, RxSight's high margins and scala...

    news image

    1 month ago · benzinga.com

    Top 3 Health Care Stocks That Are Preparing To Pump This Quarter

    The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

    news image

    1 month ago · seekingalpha.com

    RxSight, Inc. (RXST) Q1 2025 Earnings Call Transcript

    RxSight, Inc. (NASDAQ:RXST ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Oliver Moravcevic - Vice President, Investor Relations Ron Kurtz - President & Chief Executive...

    news image

    1 month ago · zacks.com

    RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates

    RxSight, Inc. (RXST) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.12 per share a year ago.

    news image

    1 month ago · zacks.com

    RxSight, Inc. (RXST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

    RxSight (RXST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    news image

    2 months ago · https://thefly.com

    RxSight price target lowered to $17 from $22 at Wells Fargo

    Wells Fargo lowered the firm's price target on RxSight to $17 from $22 and keeps an Equal Weight rating on the shares following the conference call to discuss the preliminary Q1 2025 sales results and...

    news image

    2 months ago · seekingalpha.com

    ​RxSight: Navigating Market Headwinds Amid Intensifying Competition (Downgrade)

    RxSight posted a sequential revenue decline, revealing cracks in momentum despite earlier signs of profitability. Revised 2025 outlook and lack of expected profitability suggest earlier optimism was p...

    news image

    2 months ago · seekingalpha.com

    RxSight, Inc. (RXST) Q1 2025 Preliminary Results Conference Call (Transcript)

    RxSight, Inc. (NASDAQ:RXST ) Q1 2025 Preliminary Results Conference Call April 3, 2025 8:00 AM ET Company Participants Oliver Moravcevic - VP, IR Dr. Ron Kurtz - Director, Co-President and CEO Shelley...

    Add to Watchlist